Clinical Trial Update: Primary Preventive Ventricular Tachycardia Ablation In High-Risk Patients Who Receive A Prophylactic Implantable Cardioverter Defibrillator [NA]

View source ↗

Summary

This entry notes an ongoing clinical trial evaluating primary preventive ventricular tachycardia ablation in high-risk heart failure patients who receive a prop…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Snippet

Sponsor: University of Rochester | Conditions: Heart Failure | NA | Status: RECRUITING